Evidence map›Paper›PMID 39027444›Full record

ArticleHeliyon2024

Ensemble model for grape leaf disease detection using CNN feature extractors and random forest classifier.

Farian S Ishengoma, Neema N Lyimo

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Farian S IshengomaDepartment of Informatics and Information Technology, College of Natural and Applied Sciences, Sokoine University of Agriculture, P.O. Box 3000, Morogoro, Tanzania.
Neema N LyimoDepartment of Informatics and Information Technology, College of Natural and Applied Sciences, Sokoine University of Agriculture, P.O. Box 3000, Morogoro, Tanzania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Detecting crop diseases before they spread poses a significant challenge for farmers. While both deep learning (DL) and computer vision are valuable for image classification, DL necessitates larger datasets and more extensive training periods. To overcome the limitations of working with constrained datasets, this paper proposes an ensemble model to enhance overall performance. The proposed ensemble model combines the convolution neural network (CNN)-based models as feature extractors with random forest (RF) as the output classifier. Our method is built on popular CNN-based models such as VGG16, InceptionV3, Xception, and ResNet50. Traditionally, these CNN-based architectures are referred to as one-way models, but in our approach, they are connected in parallel to form a two-way configuration, enabling the extraction of more diverse features and reducing the risk of underfitting, particularly with limited datasets. To demonstrate the effectiveness of our ensemble approach, we train models using the grape leaf dataset, which is divided into two subsets: original and modified. In the original set, background removal is applied to the images, while the modified set includes preprocessing techniques such as intensity averaging and bilateral filtering for noise reduction and image smoothing. Our findings reveal that ensemble models trained on modified images outperform those trained on the original dataset. We observe improvements of up to 5.6 % in accuracy, precision, and sensitivity, thus validating the effectiveness of our approach in enhancing disease pattern recognition within limited datasets.

Indexed as

Convolution neural networkGrapesRandom forestTwo-way model

Identifiers

PMID39027444
PMCPMC11254602

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.